http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013041182-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11e4a8db701c7366c5d00c665249959e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dfa2510a61c44d14c514c4d4d3ec1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
filingDate 2012-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e227153092f7cf3aa930ebc8bd0854c
publicationDate 2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013041182-A1
titleOfInvention Crystallization of idarubicin hydrochloride
abstract The patent application relates to a method for producing crystalline idarubicin hydrochloride, comprising the steps of (i) preparing a mixture that contains (a) idarubicin hydrochloride, (b) at least one alcohol selected from the group consisting of 1-butanol, 2-butanol and 1-pentanol, and (c) water; and (ii) crystallization of idarubicin hydrochloride from said mixture.
priorityDate 2011-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4046878-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-195417-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0287353-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1036797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005004805-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11744897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21699599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454382658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10419325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450111360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127939574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID636362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415161786

Total number of triples: 59.